Welireg 40 MG tablet 90S
Ended Awarded Last action
- Contract number
- SPE2DR26FQU9Q
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $37,872
Award facts
- Contract value 100% obligated
- $37,871.86 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $37,871.86 to AmerisourceBergen Drug Corp for the supply of Welireg (axitinib) 40 mg tablets in quantities of 90 units. The contract, awarded on January 20, 2026, with an ultimate completion date of February 10, 2026, operates under a firm fixed-price structure with no set-aside designation, indicating full and open competition. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031, which serves as the primary vehicle for delivering comprehensive pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp functions as a critical vendor within the federal medical procurement supply chain, particularly for military and veteran healthcare systems. Welireg is an oncology medication used in the treatment of renal cell carcinoma, reflecting the company's established portfolio of specialty pharmaceutical products across multiple therapeutic domains. The award demonstrates AmerisourceBergen's continued capability to compete effectively for federal pharmaceutical procurement requirements and fulfill essential medical supply needs for the Department of Defense healthcare systems through its established relationship with the Defense Logistics Agency.
Quick answers
Who was awarded contract SPE2DR26FQU9Q?
SPE2DR26FQU9Q was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 20, 2026.
How much is contract SPE2DR26FQU9Q worth?
The government has obligated $37,872 on SPE2DR26FQU9Q.
Is contract SPE2DR26FQU9Q an order under another contract?
Yes. SPE2DR26FQU9Q is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FQU9Q competed?
The extent of competition for SPE2DR26FQU9Q was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award